Prevalence of age-related macular degeneration in the Republic of Ireland

被引:37
作者
Akuffo, Kwadwo Owusu [1 ]
Nolan, John [1 ]
Stack, Jim [1 ]
Moran, Rachel [1 ]
Feeney, Joanne [2 ,3 ]
Kenny, Rose Anne [2 ]
Peto, Tunde [4 ,5 ]
Dooley, Cara [2 ]
O'Halloran, Aisling M. [2 ]
Cronin, Hilary [2 ]
Beatty, Stephen [1 ]
机构
[1] Waterford Inst Technol, Dept Chem & Life Sci, Macular Pigment Res Grp, Carriganore, Waterford, Ireland
[2] Trinity Coll Dublin, Dept Med Gerontol, Irish Longitudinal Study Ageing, Dublin, Ireland
[3] Queens Univ Belfast, Ctr Publ Hlth, Belfast BT7 1NN, Antrim, North Ireland
[4] Moorfields Eye Hosp, NIHR Biomed Res Ctr, London, England
[5] UCL Inst Ophthalmol, London, England
基金
欧洲研究理事会;
关键词
BLUE MOUNTAINS EYE; CLINICAL-TRIAL; MACULOPATHY; POPULATION;
D O I
10.1136/bjophthalmol-2014-305768
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background Age-related macular degeneration (AMD) remains the most common cause of visual loss among subjects over 50 years of age in the developed world. The Irish Longitudinal study on Ageing (TILDA) is a population-based study of subjects aged 50 years or older, designed to investigate factors that influence ageing, and has enabled this investigation of the prevalence of AMD in the Republic of Ireland (ROI). Methods Data collected from a nationally representative sample of community-living older adults aged 50 years and over in ROI over the period November 2009 to July 2011. 5035 participants attended the TILDA health centre for assessment. Retinal photographs were obtained in 4859 of these participants. Retinal grading was performed in a masked fashion using a modified version of the International Classification and Grading System for AMD. Results Adjusting for lower response rates among older subjects, the estimated overall prevalence of any AMD was 7.2% (95% CI 6.5% to 7.9%) in the population aged 50 years or older. The estimated prevalence of early AMD was 6.6% (95% CI 5.9% to 7.3%), and the estimated prevalence of late AMD was 0.6% (95% CI 0.4% to 0.8%). Statistically significant associations with AMD included increasing age and family history of the condition. Conclusions This is the first study to provide prevalence estimates of AMD in ROI and will inform eye care professionals and policymakers involved in the delivery and planning of care for those afflicted with this condition.
引用
收藏
页码:1037 / 1044
页数:8
相关论文
共 29 条
[1]   Prevalence of age-related maculopathy and age-related macular degeneration among the inuit in Greenland:: The Greenland Inuit Eye Study [J].
Andersen, Mads Varis Nis ;
Rosenberg, Thomas ;
la Cour, Morten ;
Kulgaard, Jens F. ;
Prause, Jan U. ;
Alsbirk, Poul Helge ;
Borch-Johnsen, Knut ;
Peto, Tunde ;
Carstensen, Bendix ;
Bird, Alan C. .
OPHTHALMOLOGY, 2008, 115 (04) :700-707
[2]   Prevalence of age-related maculopathy in older Europeans - The European Eye Study (EUREYE) [J].
Augood, CA ;
Vingerling, JR ;
de Jong, PTVM ;
Chakravarthy, U ;
Seland, J ;
Soubrane, G ;
Tomazzoli, L ;
Topouzis, F ;
Bentham, G ;
Rahu, M ;
Vioque, J ;
Young, IS ;
Fletcher, AE .
ARCHIVES OF OPHTHALMOLOGY, 2006, 124 (04) :529-535
[3]   AN INTERNATIONAL CLASSIFICATION AND GRADING SYSTEM FOR AGE-RELATED MACULOPATHY AND AGE-RELATED MACULAR DEGENERATION [J].
BIRD, AEC ;
BRESSLER, NM ;
BRESSLER, SB ;
CHISHOLM, IH ;
COSCAS, G ;
DAVIS, MD ;
DEJONG, PTVM ;
KLAVER, CCW ;
KLEIN, BEK ;
KLEIN, R ;
MITCHELL, P ;
SARKS, JP ;
SARKS, SH ;
SOURBANE, G ;
TAYLOR, HR ;
VINGERLING, JR .
SURVEY OF OPHTHALMOLOGY, 1995, 39 (05) :367-374
[4]   Incidence of Legal Blindness From Age-Related Macular Degeneration in Denmark: Year 2000 to 2010 [J].
Bloch, Sara Brandi ;
Larsen, Michael ;
Munch, Inger Christine .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2012, 153 (02) :209-213
[5]  
Brugiavini A, 2005, AGEING RETIREMENT EU
[6]  
Central Statistics Office, 2012, CENS 2011
[7]   Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration [J].
Chakravarthy, Usha ;
Harding, Simon P. ;
Rogers, Chris A. ;
Downes, Susan M. ;
Lotery, Andrew J. ;
Wordsworth, Sarah ;
Reeves, Barnaby C. .
OPHTHALMOLOGY, 2012, 119 (07) :1399-1411
[8]   Lutein plus Zeaxanthin and Omega-3 Fatty Acids for Age-Related Macular Degeneration The Age-Related Eye Disease Study 2 (AREDS2) Randomized Clinical Trial [J].
Chew, Emily Y. ;
Clemons, Traci E. ;
SanGiovanni, John Paul ;
Danis, Ronald ;
Ferris, Frederick L., III ;
Elman, Michael ;
Antoszyk, Andrew ;
Ruby, Alan ;
Orth, David ;
Bressler, Susan ;
Fish, Gary ;
Hubbard, Baker ;
Klein, Michael ;
Chandra, Suresh ;
Blodi, Barbara ;
Domalpally, Amitha ;
Friberg, Thomas ;
Wong, Wai ;
Rosenfeld, Philip ;
Agron, Elvira ;
Toth, Cynthia ;
Bernstein, Paul ;
Sperduto, Robert .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (19) :2005-2015
[9]   Health and Aging: Development of The Irish Longitudinal Study on Ageing Health Assessment [J].
Cronin, Hilary ;
O'Regan, Clare ;
Finucane, Ciaran ;
Kearney, Patricia ;
Kenny, Rose Anne .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2013, 61 :S269-S278
[10]   Racial differences in the prevalence of age-related macular degeneration - The Baltimore eye survey [J].
Friedman, DS ;
Katz, J ;
Bressler, NM ;
Rahmani, B ;
Tielsch, JM .
OPHTHALMOLOGY, 1999, 106 (06) :1049-1055